Related ALXNUS Stock Futures Drop Ahead Of Economic DataStrensiq Receives Marketing Approval in Japan for Treatment of Patients with HypophosphatasiaBy and large, the number of shares short in the leading biotech and emerging pharmaceutical stocks shrank between the June 15 and June 30 settlement dates.The trend was particularly noticeable in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Gilead Sciences, Inc. (NASDAQ: […]
It’s been a turbulent few days for the biotech sector with the NASDAQ Biotechnology Index declining 5.46% over the last five trading days. A major part of this decline was recorded on Monday as the sector reacted to negative pipeline updates from companies like Amgen (AMGN – Analyst Report) and Celladon (CLDN – Snapshot Report). Meanwhile, Biogen’s (BIIB – Analyst […]
Some investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.
Biotech stocks fell more than 3%, their biggest one-day drop this year.
But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains of 3% for […]
Akin Oyedele
Mar. 26, 2015, 8:22 AM
253
Wikimedia CommonsSome investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains […]
View photo.(Wikimedia Commons)Some investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains of 3% for the […]
Akin Oyedele
Mar. 26, 2015, 8:22 AM
1,134
Wikimedia CommonsSome investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains […]
By Ben LevisohnLeerink’s Howard Liang and team think 2015 will be another good year for biotech stocks like Gilead Sciences (GILD), Celgene (CELG), Amgen (AMGN ) and Alexion Pharmaceuticals (ALXN). They explain why:
Boston Globe via Getty Images
Biotech fundamentals appear strong, and could attract and broaden investor interest in the sector. Ongoing and upcoming product launches could be among the fastest […]
With the holiday season coming up, it’s been a relatively quiet week for the biotech sector with very few pipeline and regulatory updates. However, companies like Sophiris (SPHS – Snapshot Report) and Cyclacel saw their shares plunging on disappointing pipeline updates.Recap of the Week’s Most Important Stories1. Sophiris faced a major pipeline setback following an interim analysis of an ongoing […]
With the holiday season coming up, it’s been a relatively quiet week for the biotech sector with very few pipeline and regulatory updates. However, companies like Sophiris (SPHS – Snapshot Report) and Cyclacel saw their shares plunging on disappointing pipeline updates.Recap of the Week’s Most Important Stories1. Sophiris faced a major pipeline setback following an interim analysis of an ongoing […]
It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]
